KRKarine Paula Reichert

Karine Paula Reichert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karine Paula Reichert has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Vera Maria Morsch

    Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, Brazil

    5 shared publications
  • Cinthia M. Andrade

    Post-Graduate Program in Biological Sciences: Toxicological Biochemistry, CCNE, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil

    2 shared publications
  • Henning Ulrich

    Department of Microbiology and Parasitology, Health Sciences Center, Federal University of Santa Maria RS, Brazil

    2 shared publications
  • Jessie Martins Gutierres

    Affiliation Programa de Pós Graduação em Ciências Biológicas: Bioquímica Toxicológica, Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria, Santa Maria/RS, Brazil

    2 shared publications
  • Jucimara Baldissarelli

    Programa de Pós Graduação em Ciências Biológicas: Bioquímica Toxicológica, Departamento de Bioquímica e Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil

    2 shared publications
  • Maria Rosa C. Schetinger

    Post-Graduate Program in Biological Sciences: Toxicological Biochemistry, CCNE, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil

    2 shared publications

Latest Publications

  • Open Access

    Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status

    by Aniélen D. da Silva, Mateus Fracasso, Nathieli B. Bottari, Taís V. Palma, Ana M. Engelmann, Milagros F. V. Castro, Charles E. Assmann, Vitor Mostardeiro, Karine P. Reichert, Jelson Nauderer, et al.

    Background/Objectives: The Trypanosoma cruzi infection promotes an intense inflammatory process that affects several tissues. The cholinergic system may exert a regulatory immune response and control the inflammatory process. This study aimed to evaluate the comparative effect of free and nanoencapsulated benznidazole in acute T. cruzi infection to assess hematological, biochemical, and oxidative status triggered by the cholinergic system. Methods: For this, fifty female Swiss mice were distributed in eight groups, i.e., uninfected and infected animals under four treatment protocols: untreated (control—CT); vehicle treatment (Eudragit L 100—EL-100); benznidazole treatment (BNZ); and nanoencapsulated benznidazole treatment (NBNZ). After eight treatment days, the animals were euthanized for sample collection. Results: The peak of parasitemia was at day 7 p.i., and the BNZ and NBNZ controlled and reduced the parasite rate but showed no efficacy in terms of total elimination of parasites analyzed by RT-PCR in both infected groups. The infection promotes significant anemia, leukopenia, and thrombocytopenia, which the BNZ improves. There was an increase in AChE activity during infection, leading to a pro-inflammatory response and an increase in M1 and M2 mACh receptors in the BNZ group, showing that the treatment interacted with the cholinergic pathway. In addition, a pro-oxidative response was characterized in the infection and mainly in the infected BNZ and NBNZ groups. The histopathological analysis showed significative splenomegaly and inflammatory infiltrate in the heart, liver, and spleen. Conclusions: The administration of the BNZ or NBNZ reverses hematological, hepatic, and renal alterations through cholinergic signaling and stimulates a pro-inflammatory response during acute T. cruzi infection.


  • Neuroprotection elicited by resveratrol in a rat model of hypothyroidism: Possible involvement of cholinergic signaling and redox status

    by Juliane de Souza Cardoso, Jucimara Baldissarelli, Karine Paula Reichert, Fernanda Cardoso Teixeira, Mayara Sandrielly Pereira Soares, Maria Rosa Chitolina Schetinger, Vera Maria Morsch, Antônio Orlando Farias Martins Filho, Humberto Ribeiro Duarte Junior, Felipe Henrique Ribeiro Coriolano, et al.


  • Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells

    by Karine P. Reichert, Micheli M. Pillat, Maria Rosa C. Schetinger, Nathieli B. Bottari, Tais V. Palma, Charles E. Assmann, Jessie M. Gutierres, Henning Ulrich, Cinthia M. Andrade, Christopher Exley, et al.


  • Aluminum affects neural phenotype determination of embryonic neural progenitor cells

    by Karine P. Reichert, Maria Rosa C. Schetinger, Micheli M. Pillat, Nathieli B. Bottari, Tais V. Palma, Jessie M. Gutierres, Henning Ulrich, Cinthia M. Andrade, Christopher Exley, Vera M. M. Morsch

    Aluminum (Al) is a neurotoxin and is associated with the etiology of neurodegenerative diseases, such as Alzheimer’s disease (AD). The Al-free ion (Al3+) is the biologically reactive and toxic form. However, the underlying mechanisms of Al toxicity in the brain remain unclear. Here, we evaluated the effects of Al3+ (in the chloride form—AlCl3) at different concentrations (0.1–100 µM) on the morphology, proliferation, apoptosis, migration and differentiation of neural progenitor cells (NPCs) isolated from embryonic telencephalons, cultured as neurospheres. Our results reveal that Al3+ at 100 µM reduced the number and diameter of neurospheres. Cell cycle analysis showed that Al3+ had a decisive function in proliferation inhibition of NPCs during neural differentiation and induced apoptosis on neurospheres. In addition, 1 µM Al3+ resulted in deleterious effects on neural phenotype determination. Flow cytometry and immunocytochemistry analysis showed that Al3+ promoted a decrease in immature neuronal marker β3-tubulin expression and an increase in co-expression of the NPC marker nestin and glial fibrillary acidic protein. Thus, our findings indicate that Al3+ caused cellular damage and reduced proliferation and migration, resulting in global inhibition of NPC differentiation and neurogenesis.


  • Lingonberry Extract Provides Neuroprotection by Regulating the Purinergic System and Reducing Oxidative Stress in Diabetic Rats

    by Karine Paula Reichert, Maria Rosa Chitolina Schetinger, Jessie Martins Gutierres, Luana Paula Pelinson, Naiara Stefanello, Diéssica Padilha Dalenogare, Jucimara Baldissarelli, Thauan Faccin Lopes, Vera Maria Morsch

    Scope: Beneficial effects produced by polyphenolic compounds are used in the treatment of various diseases, including diabetes. Thus it is relevant to investigate the protective effect of lingonberry extract (LB) on the activities of nucleoside triphosphate diphosphohydrolase (NTPDase), 5’‐nucleotidase (5’‐NT), and adenosine deaminase (ADA); the density of A1, A2A, and P2×7 receptors; production of reactive species (RS); and the levels of thiobarbituric acid reactive substances (TBARS) in the cerebral cortex of streptozotocin‐induced diabetic rats.Methods and results: Animals were divided into five groups (n= 10): control/saline; control/LB 50 mg kg−1; diabetic/saline; diabetic/LB 25 mg kg−1; and diabetic/LB 50 mg kg−1; and treated for 30 days. Our results demonstrate that the treatment with LB increased NTPDase activity in the diabetic/LB 50 group compared to diabetic/saline group. Western blot analysis showed that LB restored the density of purinergic receptors to the approximate values of the control/saline group. An increase in the levels of RS and TBARS was observed in the diabetic/saline group compared with the control/saline group, and treatment with LB can prevent this increase.Conclusion: This study showed that LB could reverse the modifications found in the diabetic state, suggesting that lingonberry may be a coadjuvant in the treatment of diabetes.